Novocure, Verastem Oncology to Evaluate Combination Therapy for Pancreatic Cancer
Novocure and Verastem Oncology will evaluate a combination therapy for pancreatic cancer.
Related stories
Howmet Aerospace Shares Rise 5.48% to $205.90
Shares rose 5.48% to $205.90 at 11:45 a.m. ET on October 29. The report cites 45% year-over-year growth in gas-turbine revenue and expanded repurchase authorization.
M impact | EQUITY | Oct 29, 2026, 05:46 PM UTC
Tencent ADRs Fall 0.52% as Company Expands Visa Cooperation
Tencent’s U.S. ADRs fell 0.52% to $48.88 at 11:29 a.m. ET on October 29. Tencent and Visa expanded cooperation to explore cross-border payments, remittances and AI-powered shopping
M impact | EQUITY | Oct 29, 2026, 05:46 PM UTC
Alibaba Shares Fall 0.94% as It Adds Amsterdam AI Cloud Capacity
Alibaba launched cloud capacity in the Netherlands. Its shares fell 0.94% to $100.01 at 11:29 a.m. ET on October 29.
M impact | EQUITY | Oct 29, 2026, 05:46 PM UTC
Teradyne Shares Fall 4.49% to $299.16 as Guidance Nears
Teradyne shares were down 4.49% at $299.16 at 11:30 a.m. ET on October 29. The company’s next-quarter revenue guidance leaves room for modest sequential changes.
M impact | EQUITY | Oct 29, 2026, 05:46 PM UTC
Intercontinental Exchange shares rise 5.8%, on pace for best day since 2020
ICE shares were up 5.8% Thursday, their largest percentage gain since March 2020, according to Dow Jones Market Data.
M impact | EQUITY | Oct 29, 2026, 05:44 PM UTC
Teck Resources Keeps Quarterly Dividend at CA$0.125 a Share
The quarterly dividend is payable Dec. 31 to shareholders of record on Dec. 15.
M impact | EQUITY | Oct 29, 2026, 05:44 PM UTC